A detailed history of Buckingham Strategic Partners transactions in Zoetis Inc. stock. As of the latest transaction made, Buckingham Strategic Partners holds 2,487 shares of ZTS stock, worth $435,125. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,487
Previous 1,366 82.06%
Holding current value
$435,125
Previous $269,000 56.13%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $185,716 - $224,132
1,121 Added 82.06%
2,487 $420,000
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $23,624 - $31,214
-156 Reduced 10.25%
1,366 $269,000
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $49,974 - $57,638
299 Added 24.45%
1,522 $264,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $196,829 - $227,759
1,223 New
1,223 $210,000
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $200,733 - $257,515
1,287 New
1,287 $221,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Buckingham Strategic Partners Portfolio

Follow Buckingham Strategic Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Partners with notifications on news.